Clinical Trial to Evaluate the Efficacy and Safety of YHP1701

• Status: Completed
• Trial end date: 2018-04-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine superiority of YHP1701 comparing to each monotherapy in patient with hypertension and primary hypercholesterolemia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yuhan Corporation

Criteria

Inclusion Criteria:

• Both man and woman who is over 19 years old

• Patient with dyslipidemia and hypertension

Exclusion Criteria:

• sSBP difference is ≥20 mmHg or sDBP difference is ≥10 mmHg

• A history of cardiovascular disease

• Rhabdomyolysis, myopathy

• Hypertension or hypercholesterolemia due to secondary causes

• Uncontrolled diabetes

• Evidence of hepatic or renal disease